Specific Calcium Antagonists in the Treatment of Peripheral Vascular Disease
- THE TREATMENT OF PERIPHERAL VASCULAR DISEASES WITH CYCLOSPASMOL. Van Wijk, Theo W. // Angiology;Apr1953, Vol. 4 Issue 2, p103
1.A new vasodilator drug, Cyclospasmol or the mandelic acid ester of 3,5,5-trimethylcyclohexanol, proves to be a valuable asset in the treatment of peripheral vascular diseases. 2. During a period of 12-18 months, 50 patients were treated with this drug, so that a provisional opinion may be...
- Clinical Evaluation of Flunarizine: Walking Distance, Ergometric Performance, and Hemodynamic and Biochemical Effects. Rudofsky, G.; Brock, F.-E.; Ulrich, M.; Nobbe, F. // Angiology;Jul1979, Vol. 30 Issue 7, p470
Focuses on the effectiveness of flunarizine in treating occlusive arterial disease. Compensatory ability of the cardiovascular and pulmonary system; Orthopedic disturbances.
- Cochrane for Clinicians. // American Family Physician;8/1/2014, Vol. 90 Issue 3, p1
The article deals with the effectiveness of calcium channel blockers (CCB) in treating Raynaud phenomenon, which is characterized by transient digital ischemia caused by vasoconstriction resulting from cold or emotional distress. Data is presented from a 2005 study indicating the potential of...
- Does felodipine improve circulation in peripheral vascular disease? // Age & Ageing;May98, Vol. 27 Issue 3, p266
Provides information on an article appearing in the periodical `Vascular Medicine' volume 2, investigating whether felodipine improves circulation in peripheral vascular disease.
- Peripheral arterial disease: 5 steps to a better outcome. Donaldson, Magruder C.; Olin, Jeffrey W. // Patient Care;1/15/1996, Vol. 30 Issue 1, p22
Offers advice for physicians on treating peripheral arterial disease. Need to increase awareness of the prevalence and clinical significance of the disease; Tips on improving knowledge on the diagnosis of the disease; Understanding the value of structured exercise programs; Tips on referring...
- ACTION OF BETA-PYRIDIL CARBINOL (RONIACOL) ON THE PERIPHERAL CIRCULATION OF NORMAL PERSONS AND IN CERTAIN PATHOLOGIC STATES. Castro, Carlos M.; de Soldati, Le�n // Angiology;Apr1953, Vol. 4 Issue 2, p165
Reports on a study to test the effect of beta-pyridil carbinol, available under the name of Roniacol, on a group of 40 subjects, 17 without peripheral angiopathy. Oral, intramuscular, intravenous and intra-arterial administration of Roniacol; Vasodilatory action which was shown fundamentally at...
- Pentoxifylline Studies. // Life Extension;Jan2002, Vol. 8 Issue 1, p18
Provides information on pentoxifylline (PTX), a prescription drug approved by the U.S. Food and Drug Administration to treat peripheral vascular disease. Standard dosage; Findings of a controlled study on human diabetics with advanced renal failure; Effect of PTX in a group of pediatric lupus...
- DEB adoption on the rise in Europe. // Medical Device Daily;7/5/2011, Vol. 15 Issue 122, p9
The article reports on the growing number of European doctors who use drug-eluting balloons (DEBs) in peripheral vascular treatment, according to the Millennium Research Group.
- Standard exercise test to assess peripheral arterial disease. Laing, Susan P.; Greenhalgh, Roger M. // British Medical Journal;1/5/1980, Vol. 280 Issue 6206, p13
Assesses peripheral arterial disease via standard exercise test. Indications of severity of hemodynamics; Effects of workloads on pressure response; Measurement of disability by claudication distance.